パーキンソン病:グローバル医薬品市場予測及び分析(~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 27
3.1.3 Prognosis 29
3.1.4 Quality of Life 30
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 32
4.2.1 The risk of developing Parkinson’s disease progressively increases with age 33
4.2.2 The risk for Parkinson’s disease is increased with Parkinson’s disease-causing mutations 34
4.2.3 Men are 1.5 times more likely to develop Parkinson’s disease than women, though the difference may be the result of varying exposures to environmental factors 34
4.2.4 Chemicals, along with exposure to other environmental factors, increase the risk of developing Parkinson’s disease 35
4.2.5 38% of Parkinson’s disease cases experienced depression and/or anxiety compared with only 8% of controls 35
4.3 Global and Historical Trends 36
4.3.1 US 36
4.3.2 5EU 37
4.3.3 Japan 37
4.3.4 Brazil 38
4.4 Forecast Methodology 39
4.4.1 Sources Used 40
4.4.2 Sources Not Used 43
4.4.3 Forecast Assumptions and Methods 43
4.5 Epidemiological Forecast of Parkinson’s Disease (2012-2022) 44
4.5.1 Prevalent Cases of Parkinson’s Disease 44
4.5.2 Age-Specific Prevalent Cases of Parkinson’s Disease 46
4.5.3 Sex-Specific Prevalent Cases of Parkinson’s Disease 48
4.5.4 Age-Standardized Prevalence of Parkinson’s Disease 49
4.6 Discussion 50
4.6.1 Epidemiological Forecast Insight 50
4.6.2 Limitations of the Analysis 51
4.6.3 Strengths of the Analysis 52
5 Disease Management 53
5.1 Overview 53
5.1.1 Diagnosis – The UK Brain Bank Criteria 53
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 54
5.2 Treatment Synopsis 57
5.2.1 Dopaminergic Therapy Classes 57
5.2.2 Treatment of Parkinson’s Disease by Stage 59
5.2.3 Other Treatment Options 62
5.3 Parkinson’s Disease Assessment Scales 62
5.3.1 Unified Parkinson’s Disease Rating Scale (UPDRS) 63
5.3.2 Hoehn and Yahr Clinical Staging 65
5.3.3 Other Clinical Assessments 66
5.4 Diagnosis and Treatment of Parkinson’s Disease by Country 66
5.4.1 US 66
5.4.2 France 68
5.4.3 Germany 70
5.4.4 Italy 72
5.4.5 Spain 75
5.4.6 UK 77
5.4.7 Japan 78
5.4.8 Brazil 81
6 Competitive Assessment 84
6.1 Overview 84
6.2 Strategic Competitor Assessment 86
6.3 Product Profiles – Levodopa Combination Therapy 87
6.3.1 Madopar (levodopa/benserazide) 88
6.3.2 Sinemet (carbidopa/levodopa) 93
6.3.3 Duodopa (carbidopa/levodopa intestinal gel) 99
6.4 Product Profiles – COMT Inhibitors 103
6.4.1 Stalevo/Comtan (entacapone) 103
6.5 Dopamine Agonists 109
6.5.1 Neupro (rotigotine transdermal patch) 110
6.5.2 Requip/Requip XL (ropinirole) 117
6.5.3 Apokyn (apomorphine) 121
6.6 Product Profiles – MAO-B Inhibitors 126
6.6.1 Azilect (rasagiline) 127
6.7 Product Profiles – Adenosine 2A Inhibitor 133
6.7.1 Nouriast (istradefylline) 134
6.8 Product Profiles – Other Therapies 137
7 Opportunity and Unmet Need 139
7.1 Overview 139
7.2 Treatment of Motor Complications – Dyskinesias and OFF Episodes 141
7.2.1 Unmet Need 141
7.2.2 Gap Analysis 143
7.2.3 Opportunity 146
7.3 Treatment of Non-Motor Symptoms and Dementia 146
7.3.1 Unmet Need 146
7.3.2 Gap Analysis 147
7.3.3 Opportunity 149
7.4 Neuroprotective/Disease-Modifying Agents 149
7.4.1 Unmet Need 149
7.4.2 Gap Analysis 150
7.4.3 Opportunity 153
7.5 Improved Drug Formulations 154
7.5.1 Unmet Need 154
7.5.2 Gap Analysis 154
7.5.3 Opportunity 155
7.6 Identification of Reliable Biomarkers 155
7.6.1 Unmet Need 155
7.6.2 Gap Analysis 156
7.6.3 Opportunity 157
7.7 Improved Clinical Trial Design 157
7.7.1 Unmet Need 157
7.7.2 Gap Analysis 158
7.7.3 Opportunity 158
8 Pipeline Assessment 159
8.1 Overview 159
8.2 Clinical Trial Mapping 159
8.2.1 Clinical Trials by Class/Patient Population/Biomarkers/Line of Therapy 159
8.3 Promising Drugs in Clinical Development 161
8.3.1 Safinamide 163
8.3.2 Tozadenant 171
8.3.3 CVT-301 175
8.3.4 Rytary/IPX066 181
8.3.5 Opicapone 188
8.3.6 Mavoglurant/AFQ056 193
8.3.7 CD/LD-GR 196
8.3.8 Other Late-Stage Pipeline Products 201
9 Current and Future Players 202
9.1 Overview 202
9.2 Trends in Corporate Strategy 203
9.3 Company Profiles 204
9.3.1 Merck 204
9.3.2 Roche 206
9.3.3 AbbVie 208
9.3.4 UCB 210
9.3.5 GlaxoSmithKline 211
9.3.6 Novartis 213
9.3.7 Orion 216
9.3.8 Newron 217
9.3.9 Civitas 219
9.3.10 Impax 221
9.3.11 Lundbeck 223
10 Market Outlook 226
10.1 Global Markets 226
10.1.1 Forecast 226
10.1.2 Drivers and Barriers – Global Issues 230
10.2 US 232
10.2.1 Forecast 232
10.2.2 Key Events 237
10.2.3 Drivers and Barriers 237
10.3 France 239
10.3.1 Forecast 239
10.3.2 Key Events 243
10.3.3 Drivers and Barriers 243
10.4 Germany 245
10.4.1 Forecast 245
10.4.2 Key Events 249
10.4.3 Drivers and Barriers 249
10.5 Italy 251
10.5.1 Forecast 251
10.5.2 Key Events 255
10.5.3 Drivers and Barriers 255
10.6 Spain 257
10.6.1 Forecast 257
10.6.2 Key Events 262
10.6.3 Drivers and Barriers 262
10.7 UK 264
10.7.1 Forecast 264
10.7.2 Key Events 268
10.7.3 Drivers and Barriers 268
10.8 Japan 270
10.8.1 Forecast 270
10.8.2 Key Events 274
10.8.3 Drivers and Barriers 274
10.9 Brazil 276
10.9.1 Forecast 276
10.9.2 Key Events 280
10.9.3 Drivers and Barriers 280
11 Appendix 282
11.1 Bibliography 282
11.2 Abbreviations 300
11.3 Methodology 305
11.4 Forecasting Methodology 305
11.4.1 Diagnosed Parkinson’s Disease Patients 305
11.4.2 Percent Drug-Treated Patients 306
11.4.3 Drugs Included in Each Therapeutic Class 306
11.4.4 Launch and Patent Expiry Dates 307
11.4.5 General Pricing Assumptions 308
11.4.6 Compliance Assumptions 309
11.4.7 Individual Drug Assumptions 310
11.4.8 Generic Erosion 320
11.4.9 Pricing of Pipeline Agents 320
11.5 Physicians and Specialists Included in this Study 321
11.6 About the Authors 323
11.6.1 Author 323
11.6.2 Epidemiologist 324
11.6.3 Global Head of Healthcare 325
11.7 About GlobalData 326
11.8 Disclaimer 326


【レポート販売概要】

■ タイトル:パーキンソン病:グローバル医薬品市場予測及び分析(~2022)
■ 英文:PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022
■ 発行日:2014年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC82PIDR
■ 調査対象地域:グローバル
  • 配電自動化ソリューションの世界市場
    ABSTRACTAbout Distribution Automation Solutions Distribution automation can be defined as the evolution of control technologies that help in optimizing and improving the electricity distribution and reliability of overall power distribution network. It is a smart grid technology that can be employed in the power distribution system of local power lines and neighborhood substations. The distributio …
  • ロードバンク(負荷試験装置)の世界市場2017-2021
    About Load Bank Load banks offer one of the most flexible ways to validate critical power systems and components. Load bank testing of power systems includes validating the operational conditions and output of electrical power systems such as generators, gas turbines, transformers, HVAC systems, UPS, batteries, and relays in various industries like oil and gas, power, healthcare, marine and defens …
  • ERPソフトウェアの世界市場:コンポーネント別、展開モデル別、業務機能別、エンドユーザー別、業種別、
    Enterprise resource planning (ERP) is a software that enables organizations to manage and automate their business processes. This software has been widely used for back-office operations, which include inventory control production, order management, accounting, human resource (HR), and others. An ERP software system comprises several software modules, and each ERP module is focused on a particular …
  • 海軍戦闘システムの世界市場2017-2021
    About naval combat systemsA naval combat system is an integrated system for naval vessels that are fitted with command and control, communication, surveillance, and firearm-launching equipment. Technavio’s analysts forecast the global naval combat systems market to grow at a CAGR of 3.48% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth pr …
  • マタニティー用パーソナルケア製品の世界市場2016-2020
    About Global Maternity Personal Care Products Market The global maternity personal care products market is driven by several factors — growing awareness about the risks associated with the use of regular personal care products manufactured with chemical ingredients being one of the most important. Toxic ingredients found in many personal care products have been directly associated with the increas …
  • スマートファクトリー製品の世界市場:製品ライフサイクル管理 (PLM)、製造実行システム (MES)、産業オートメーション機器
    Smart factory concept marks the beginning of a new phase of manufacturing characterized by complete automation, increasing use of technology and field devices in and out of the manufacturing facility. Smart factory not only brings the cyber physical system at the forefront of manufacturing but also connects every process and player across the value chain, thereby, aiming to achieve zero-waste prod …
  • 手術用縫合糸の世界市場予測(~2021年):天然縫合糸、ナイロン製縫合糸、ステンレス製縫合糸、シルク製縫合糸
    The surgical sutures market is projected to reach USD 4.40 billion by 2021 from USD 3.46 billion in 2016, at a CAGR of 5% during the forecast period. The market for surgical sutures is expanding due to the increasing number of surgical procedures, favorable reimbursement scenario for a number of surgical procedures, and the launch of advanced sutures. On the other hand, increasing preference for m …
  • ボクシング用品の世界市場2017-2021:ボクシンググローブ、防具、トレーニング器具
    About Boxing EquipmentBoxing has been slowly gaining popularity with the increasing participation in fitness boxing, especially by women in developed countries like the US. In the US, the participation in fitness boxing is more from women while men engage more in boxing. The growing popularity of boxing, leading to the sport becoming one of the widely-telecasted sports, is one of the key drivers o …
  • 世界の排熱回収ボイラ(HRSG)市場(2014-2018)
    About Heat Recovery Steam Generators A heat recovery steam generator is a system used to extract useful heat from the exhaust of combustion turbines or hot gas streams. It has advantages over normal boilers in terms of resource efficiency and environmental friendliness. The steam extracted may be used by steam turbines to produce electricity. It can also be used for other factory processes such as …
  • 世界のテキーラ(アルコール飲料)市場
    About Tequila Tequila is a distilled beverage made from blue agave plant located in the Mexican city of Tequila. It usually has an alcohol content of 38-40 percent by volume. Tequila accounts for a very small share in the Global Alcohol industry; however, the demand for the tequila is rising rapidly. In 2013, the Global Tequila market was dominated by the US in terms of volume as well as revenue. …
  • Epedigreeソフトウェアの世界市場2016-2020
    About ePedigree An ePedigree is an electronic record that takes care of the pedigree requirements of a drug. A pedigree contains information regarding the various levels of transactions resulting from a change of drug ownership from manufacturers to wholesalers to retailers. The record includes different important information such as the date of the transaction and the details (names and addresses …
  • スマートロボットの世界市場:個人向けサービスロボット、スマートモバイルロボット、協力ロボット
    About the Smart Robots Market Robotic vacuum cleaners emerged in the market in the late 1990s and early 2000s. However, the adoption of robotic vacuum cleaners remained low during the both the periods due to product inefficiencies like limited suction power and random movement pattern to clean floors. However, technological innovations, availability of new advanced products such as infrared sensor …
  • モノマー市場動向:January 2013
    Monomer World - January 2013 Summary Global monomer prices in January 2013 received a boost due to increases in feedstock cost and improved demand in key regions. In most regions, the tight supply conditions were attributed to low operating rates or numerous maintenance turnarounds. Scope - Analyses monthly price trends in Asia, Europe and North America region - Details significant developments in …
  • 世界及び中国の4, 4-ビフェノール市場2015
    Global and Chinese 4, 4-Biphenol Industry Report 2015 is a professional and in-depth study on the current state of the 4, 4-Biphenol industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The 4, 4-Biphenol market analysis is provided for the international markets including development trends, competitive lan …
  • 風力タービン用ギアオイルの世界市場2016-2020
    About the Wind Turbine Gear Oil Market Wind power refers to the conversion of the kinetic energy of wind into electrical energy, which can be used by grids for distribution to end-users. Although known to users since prehistoric times, the use of wind energy as a mainstream power supply has been limited. Wind energy accounted for 0.21% of the global electricity net generation in 2000. In 2010, win …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。